share_log

B. Riley Securities Reiterates Buy on Journey Medical, Maintains $6 Price Target

B. Riley Securities Reiterates Buy on Journey Medical, Maintains $6 Price Target

B. 莱利证券重申买入Journey Medical,维持6美元的目标股价
Benzinga ·  2023/09/07 08:57

B. Riley Securities analyst Kalpit Patel reiterates Journey Medical (NASDAQ:DERM) with a Buy and maintains $6 price target.

B. Riley Securities分析师卡尔皮特·帕特尔重申Journey Medical(纳斯达克股票代码:DERM)买入并维持6美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发